Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 19 |
NetGPI | no | yes: 0, no: 19 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HEZ0
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 20 |
GO:0006259 | DNA metabolic process | 4 | 20 |
GO:0006281 | DNA repair | 5 | 20 |
GO:0006310 | DNA recombination | 5 | 20 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 20 |
GO:0006807 | nitrogen compound metabolic process | 2 | 20 |
GO:0006950 | response to stress | 2 | 20 |
GO:0006974 | DNA damage response | 4 | 20 |
GO:0008152 | metabolic process | 1 | 20 |
GO:0009987 | cellular process | 1 | 20 |
GO:0033554 | cellular response to stress | 3 | 20 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 20 |
GO:0043170 | macromolecule metabolic process | 3 | 20 |
GO:0044237 | cellular metabolic process | 2 | 20 |
GO:0044238 | primary metabolic process | 2 | 20 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 20 |
GO:0046483 | heterocycle metabolic process | 3 | 20 |
GO:0050896 | response to stimulus | 1 | 20 |
GO:0051716 | cellular response to stimulus | 2 | 20 |
GO:0071704 | organic substance metabolic process | 2 | 20 |
GO:0090304 | nucleic acid metabolic process | 4 | 20 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 20 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 20 |
GO:0003824 | catalytic activity | 1 | 20 |
GO:0003909 | DNA ligase activity | 4 | 20 |
GO:0003910 | DNA ligase (ATP) activity | 5 | 20 |
GO:0005488 | binding | 1 | 20 |
GO:0005524 | ATP binding | 5 | 20 |
GO:0016874 | ligase activity | 2 | 20 |
GO:0016886 | ligase activity, forming phosphoric ester bonds | 3 | 20 |
GO:0017076 | purine nucleotide binding | 4 | 20 |
GO:0030554 | adenyl nucleotide binding | 5 | 20 |
GO:0032553 | ribonucleotide binding | 3 | 20 |
GO:0032555 | purine ribonucleotide binding | 4 | 20 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 20 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 20 |
GO:0036094 | small molecule binding | 2 | 20 |
GO:0043167 | ion binding | 2 | 20 |
GO:0043168 | anion binding | 3 | 20 |
GO:0097159 | organic cyclic compound binding | 2 | 20 |
GO:0097367 | carbohydrate derivative binding | 2 | 20 |
GO:0140097 | catalytic activity, acting on DNA | 3 | 20 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 20 |
GO:1901265 | nucleoside phosphate binding | 3 | 20 |
GO:1901363 | heterocyclic compound binding | 2 | 20 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 26 | 30 | PF00656 | 0.222 |
CLV_C14_Caspase3-7 | 413 | 417 | PF00656 | 0.413 |
CLV_NRD_NRD_1 | 10 | 12 | PF00675 | 0.547 |
CLV_NRD_NRD_1 | 246 | 248 | PF00675 | 0.262 |
CLV_NRD_NRD_1 | 430 | 432 | PF00675 | 0.319 |
CLV_NRD_NRD_1 | 437 | 439 | PF00675 | 0.322 |
CLV_PCSK_FUR_1 | 8 | 12 | PF00082 | 0.504 |
CLV_PCSK_KEX2_1 | 10 | 12 | PF00082 | 0.495 |
CLV_PCSK_KEX2_1 | 16 | 18 | PF00082 | 0.473 |
CLV_PCSK_KEX2_1 | 246 | 248 | PF00082 | 0.272 |
CLV_PCSK_KEX2_1 | 301 | 303 | PF00082 | 0.306 |
CLV_PCSK_KEX2_1 | 375 | 377 | PF00082 | 0.277 |
CLV_PCSK_KEX2_1 | 429 | 431 | PF00082 | 0.303 |
CLV_PCSK_KEX2_1 | 94 | 96 | PF00082 | 0.453 |
CLV_PCSK_PC1ET2_1 | 16 | 18 | PF00082 | 0.460 |
CLV_PCSK_PC1ET2_1 | 301 | 303 | PF00082 | 0.314 |
CLV_PCSK_PC1ET2_1 | 375 | 377 | PF00082 | 0.284 |
CLV_PCSK_PC1ET2_1 | 429 | 431 | PF00082 | 0.312 |
CLV_PCSK_PC1ET2_1 | 94 | 96 | PF00082 | 0.296 |
CLV_PCSK_SKI1_1 | 127 | 131 | PF00082 | 0.364 |
CLV_PCSK_SKI1_1 | 170 | 174 | PF00082 | 0.343 |
CLV_PCSK_SKI1_1 | 348 | 352 | PF00082 | 0.369 |
CLV_PCSK_SKI1_1 | 404 | 408 | PF00082 | 0.446 |
CLV_PCSK_SKI1_1 | 439 | 443 | PF00082 | 0.320 |
CLV_PCSK_SKI1_1 | 444 | 448 | PF00082 | 0.325 |
DEG_SIAH_1 | 337 | 345 | PF03145 | 0.374 |
DOC_CKS1_1 | 420 | 425 | PF01111 | 0.271 |
DOC_CKS1_1 | 47 | 52 | PF01111 | 0.338 |
DOC_MAPK_gen_1 | 94 | 101 | PF00069 | 0.576 |
DOC_MAPK_MEF2A_6 | 220 | 227 | PF00069 | 0.254 |
DOC_PP1_RVXF_1 | 125 | 132 | PF00149 | 0.512 |
DOC_PP1_RVXF_1 | 390 | 397 | PF00149 | 0.379 |
DOC_PP2B_LxvP_1 | 231 | 234 | PF13499 | 0.300 |
DOC_PP4_FxxP_1 | 131 | 134 | PF00568 | 0.506 |
DOC_PP4_FxxP_1 | 420 | 423 | PF00568 | 0.407 |
DOC_USP7_UBL2_3 | 251 | 255 | PF12436 | 0.220 |
DOC_USP7_UBL2_3 | 425 | 429 | PF12436 | 0.406 |
DOC_WW_Pin1_4 | 164 | 169 | PF00397 | 0.350 |
DOC_WW_Pin1_4 | 173 | 178 | PF00397 | 0.276 |
DOC_WW_Pin1_4 | 250 | 255 | PF00397 | 0.280 |
DOC_WW_Pin1_4 | 276 | 281 | PF00397 | 0.254 |
DOC_WW_Pin1_4 | 419 | 424 | PF00397 | 0.331 |
DOC_WW_Pin1_4 | 46 | 51 | PF00397 | 0.329 |
LIG_14-3-3_CanoR_1 | 64 | 72 | PF00244 | 0.355 |
LIG_14-3-3_CanoR_1 | 8 | 14 | PF00244 | 0.429 |
LIG_APCC_ABBA_1 | 216 | 221 | PF00400 | 0.158 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.294 |
LIG_BIR_III_2 | 29 | 33 | PF00653 | 0.219 |
LIG_BRCT_BRCA1_1 | 1 | 5 | PF00533 | 0.371 |
LIG_BRCT_BRCA1_1 | 127 | 131 | PF00533 | 0.493 |
LIG_BRCT_BRCA1_1 | 280 | 284 | PF00533 | 0.392 |
LIG_BRCT_BRCA1_1 | 355 | 359 | PF00533 | 0.343 |
LIG_deltaCOP1_diTrp_1 | 433 | 441 | PF00928 | 0.158 |
LIG_FHA_1 | 222 | 228 | PF00498 | 0.355 |
LIG_FHA_2 | 164 | 170 | PF00498 | 0.400 |
LIG_FHA_2 | 24 | 30 | PF00498 | 0.396 |
LIG_LIR_Apic_2 | 128 | 134 | PF02991 | 0.486 |
LIG_LIR_Gen_1 | 235 | 245 | PF02991 | 0.343 |
LIG_LIR_Gen_1 | 285 | 296 | PF02991 | 0.310 |
LIG_LIR_Gen_1 | 443 | 453 | PF02991 | 0.315 |
LIG_LIR_Gen_1 | 71 | 80 | PF02991 | 0.331 |
LIG_LIR_LC3C_4 | 150 | 153 | PF02991 | 0.179 |
LIG_LIR_Nem_3 | 124 | 129 | PF02991 | 0.388 |
LIG_LIR_Nem_3 | 235 | 241 | PF02991 | 0.325 |
LIG_LIR_Nem_3 | 265 | 269 | PF02991 | 0.272 |
LIG_LIR_Nem_3 | 285 | 291 | PF02991 | 0.309 |
LIG_LIR_Nem_3 | 29 | 34 | PF02991 | 0.284 |
LIG_LIR_Nem_3 | 356 | 362 | PF02991 | 0.267 |
LIG_LIR_Nem_3 | 377 | 381 | PF02991 | 0.325 |
LIG_LIR_Nem_3 | 388 | 394 | PF02991 | 0.371 |
LIG_LIR_Nem_3 | 443 | 448 | PF02991 | 0.327 |
LIG_LIR_Nem_3 | 71 | 75 | PF02991 | 0.346 |
LIG_MYND_1 | 213 | 217 | PF01753 | 0.300 |
LIG_PCNA_PIPBox_1 | 260 | 269 | PF02747 | 0.300 |
LIG_PCNA_yPIPBox_3 | 255 | 267 | PF02747 | 0.312 |
LIG_PDZ_Class_3 | 472 | 477 | PF00595 | 0.523 |
LIG_PDZ_Wminus1_1 | 475 | 477 | PF00595 | 0.508 |
LIG_PTAP_UEV_1 | 279 | 284 | PF05743 | 0.314 |
LIG_REV1ctd_RIR_1 | 195 | 204 | PF16727 | 0.314 |
LIG_SH2_CRK | 126 | 130 | PF00017 | 0.382 |
LIG_SH2_CRK | 19 | 23 | PF00017 | 0.466 |
LIG_SH2_CRK | 288 | 292 | PF00017 | 0.284 |
LIG_SH2_CRK | 335 | 339 | PF00017 | 0.358 |
LIG_SH2_SRC | 371 | 374 | PF00017 | 0.259 |
LIG_SH2_STAP1 | 273 | 277 | PF00017 | 0.326 |
LIG_SH2_STAT3 | 273 | 276 | PF00017 | 0.413 |
LIG_SH2_STAT5 | 115 | 118 | PF00017 | 0.479 |
LIG_SH2_STAT5 | 266 | 269 | PF00017 | 0.300 |
LIG_SH2_STAT5 | 306 | 309 | PF00017 | 0.404 |
LIG_SH2_STAT5 | 445 | 448 | PF00017 | 0.310 |
LIG_SH3_2 | 424 | 429 | PF14604 | 0.158 |
LIG_SH3_3 | 277 | 283 | PF00018 | 0.289 |
LIG_SH3_3 | 364 | 370 | PF00018 | 0.300 |
LIG_SH3_3 | 421 | 427 | PF00018 | 0.158 |
LIG_SH3_3 | 456 | 462 | PF00018 | 0.295 |
LIG_SUMO_SIM_par_1 | 221 | 228 | PF11976 | 0.323 |
LIG_TYR_ITIM | 448 | 453 | PF00017 | 0.314 |
LIG_UBA3_1 | 215 | 220 | PF00899 | 0.413 |
LIG_UBA3_1 | 363 | 368 | PF00899 | 0.292 |
MOD_CDK_SPK_2 | 173 | 178 | PF00069 | 0.286 |
MOD_CDK_SPK_2 | 250 | 255 | PF00069 | 0.158 |
MOD_CDK_SPxK_1 | 164 | 170 | PF00069 | 0.158 |
MOD_CDK_SPxK_1 | 419 | 425 | PF00069 | 0.356 |
MOD_CK1_1 | 278 | 284 | PF00069 | 0.331 |
MOD_CK1_1 | 322 | 328 | PF00069 | 0.158 |
MOD_CK2_1 | 157 | 163 | PF00069 | 0.370 |
MOD_Cter_Amidation | 373 | 376 | PF01082 | 0.284 |
MOD_Cter_Amidation | 8 | 11 | PF01082 | 0.307 |
MOD_GlcNHglycan | 273 | 276 | PF01048 | 0.347 |
MOD_GlcNHglycan | 280 | 283 | PF01048 | 0.379 |
MOD_GSK3_1 | 121 | 128 | PF00069 | 0.497 |
MOD_GSK3_1 | 271 | 278 | PF00069 | 0.284 |
MOD_GSK3_1 | 42 | 49 | PF00069 | 0.303 |
MOD_GSK3_1 | 440 | 447 | PF00069 | 0.442 |
MOD_N-GLC_1 | 163 | 168 | PF02516 | 0.278 |
MOD_N-GLC_1 | 23 | 28 | PF02516 | 0.271 |
MOD_N-GLC_1 | 51 | 56 | PF02516 | 0.412 |
MOD_N-GLC_1 | 97 | 102 | PF02516 | 0.522 |
MOD_NEK2_1 | 121 | 126 | PF00069 | 0.445 |
MOD_NEK2_1 | 156 | 161 | PF00069 | 0.240 |
MOD_NEK2_1 | 22 | 27 | PF00069 | 0.300 |
MOD_PIKK_1 | 353 | 359 | PF00454 | 0.319 |
MOD_PIKK_1 | 452 | 458 | PF00454 | 0.316 |
MOD_PK_1 | 319 | 325 | PF00069 | 0.158 |
MOD_PKA_1 | 301 | 307 | PF00069 | 0.319 |
MOD_PKA_2 | 301 | 307 | PF00069 | 0.319 |
MOD_PKA_2 | 467 | 473 | PF00069 | 0.514 |
MOD_PKA_2 | 63 | 69 | PF00069 | 0.331 |
MOD_PKA_2 | 9 | 15 | PF00069 | 0.374 |
MOD_Plk_1 | 23 | 29 | PF00069 | 0.275 |
MOD_Plk_1 | 97 | 103 | PF00069 | 0.570 |
MOD_Plk_4 | 221 | 227 | PF00069 | 0.339 |
MOD_Plk_4 | 42 | 48 | PF00069 | 0.284 |
MOD_ProDKin_1 | 164 | 170 | PF00069 | 0.350 |
MOD_ProDKin_1 | 173 | 179 | PF00069 | 0.276 |
MOD_ProDKin_1 | 250 | 256 | PF00069 | 0.280 |
MOD_ProDKin_1 | 276 | 282 | PF00069 | 0.254 |
MOD_ProDKin_1 | 419 | 425 | PF00069 | 0.331 |
MOD_ProDKin_1 | 46 | 52 | PF00069 | 0.330 |
MOD_SUMO_rev_2 | 345 | 350 | PF00179 | 0.158 |
MOD_SUMO_rev_2 | 388 | 394 | PF00179 | 0.480 |
MOD_SUMO_rev_2 | 413 | 420 | PF00179 | 0.158 |
TRG_DiLeu_BaEn_1 | 221 | 226 | PF01217 | 0.158 |
TRG_DiLeu_BaEn_1 | 286 | 291 | PF01217 | 0.284 |
TRG_DiLeu_BaLyEn_6 | 259 | 264 | PF01217 | 0.413 |
TRG_ENDOCYTIC_2 | 126 | 129 | PF00928 | 0.393 |
TRG_ENDOCYTIC_2 | 19 | 22 | PF00928 | 0.322 |
TRG_ENDOCYTIC_2 | 266 | 269 | PF00928 | 0.295 |
TRG_ENDOCYTIC_2 | 288 | 291 | PF00928 | 0.304 |
TRG_ENDOCYTIC_2 | 383 | 386 | PF00928 | 0.374 |
TRG_ENDOCYTIC_2 | 445 | 448 | PF00928 | 0.306 |
TRG_ENDOCYTIC_2 | 450 | 453 | PF00928 | 0.302 |
TRG_ER_diArg_1 | 245 | 247 | PF00400 | 0.284 |
TRG_ER_diArg_1 | 430 | 432 | PF00400 | 0.348 |
TRG_ER_diArg_1 | 8 | 11 | PF00400 | 0.461 |
TRG_NLS_Bipartite_1 | 301 | 316 | PF00514 | 0.359 |
TRG_Pf-PMV_PEXEL_1 | 11 | 15 | PF00026 | 0.273 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PAX3 | Leptomonas seymouri | 78% | 96% |
A0A0S4KIC5 | Bodo saltans | 32% | 84% |
A0A0S4KP75 | Bodo saltans | 35% | 100% |
A0A1X0NS61 | Trypanosomatidae | 31% | 91% |
A0A1X0NSF5 | Trypanosomatidae | 61% | 91% |
A0A3Q8IDN6 | Leishmania donovani | 89% | 100% |
A0A3Q8IDV4 | Leishmania donovani | 25% | 100% |
A0A3S5IR98 | Trypanosoma rangeli | 35% | 98% |
A0A422NIS8 | Trypanosoma rangeli | 59% | 100% |
A4HEY9 | Leishmania braziliensis | 27% | 100% |
A4I263 | Leishmania infantum | 25% | 100% |
A4I264 | Leishmania infantum | 89% | 100% |
C9ZRT4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 55% | 93% |
C9ZRT5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 31% | 99% |
E9AYB4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
P0C991 | African swine fever virus (isolate Warthog/Namibia/Wart80/1980) | 25% | 100% |
P0C992 | African swine fever virus (isolate Pig/Kenya/KEN-50/1950) | 25% | 100% |
Q4Q959 | Leishmania major | 88% | 100% |
V5AUB9 | Trypanosoma cruzi | 62% | 91% |
V5DAB4 | Trypanosoma cruzi | 33% | 98% |